Smith Magenis Syndrome
3
0
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Hourly Dosing Of The Nychtemeral Secretion Of Melatonin
Research Leaders
5 sponsors active, led by University of North Carolina, Chapel Hill
Related Conditions
Often studied with 13 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Parent and Infant Inter(X)Action Intervention (PIXI)
Melatonin in Adults With SMS
Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)
Research Network
Common Treatments
- Hourly Dosing Of The Nychtemeral Secretion Of Melatonin1
- Parentinfant Interxaction Intervention Pixi1
Active Sponsors
- University of North Carolina, Chapel Hill1
- Vanda Pharmaceuticals1
- RTI International1
- Hôpital le Vinatier1
- Hospices Civils de Lyon1
Top Investigators
CH LE VINATIER
RTI International
Related Conditions
- Williams Syndrome1
- Tuberous Sclerosis1
- Klinefelter Syndrome1
- Turner Syndrome1
- Duchenne Muscular Dystrophy1